BJDX
Bluejay Diagnostics, Inc.
Key Financials
Net Income
$-6848483
↑ 11.3%
Operating Income
$-6952972
↑ 3.0%
Gross Profit
$48911
0.0%
Revenue
$249040
0.0%
Total Liabilities
$1.1M
↑ 23.3%
EPS (Diluted)
$-15.25
↑ 86.6%
Total Assets
$7.1M
↑ 6.9%
Shareholders' Equity
$6.0M
↑ 4.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| PRE 14A | 4/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BJDX |
| Company Name | Bluejay Diagnostics, Inc. |
| CIK | 1704287 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (978) 631-0152 |